Want to see CRVS full AI Analyst Report?
ETFs with Corvus Pharmaceuticals (CRVS) Exposure
The following ETFs maintain exposure to Corvus Pharmaceuticals (CRVS). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
60 ETFs Hold Corvus Pharmaceuticals (CRVS)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in CRVS |
|---|---|---|---|---|---|---|
| LFSC | F/M Emerald Life Sciences Innovation ETF | $125.43M | 0.54% | 1.41% | $1.77M | 0.21% |
| CANC | Tema Oncology ETF | $216.18M | 0.75% | 0.71% | $1.53M | 0.18% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.65% | $224.67K | 0.03% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 0.56% | $1.03M | 0.12% |
| XDNA | iShares Genomics Immunology and Healthcare Index ETF Trust Units | $21.79M | 0.52% | 0.55% | $120.57K | 0.01% |
| IDNA | iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | $337.92M | 0.47% | 0.55% | $1.83M | 0.22% |
| TMED | T. Rowe Price Health Care ETF | $34.83M | 0.44% | 0.41% | $144.26K | 0.02% |
| SURI | Simplify Propel Opportunities ETF | $75.80M | 2.56% | 0.34% | $250.75K | 0.03% |
| TDNA | T. Rowe Price Biotech ETF | $11.32M | 0.55% | 0.33% | $36.93K | <0.01% |
| XBI | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | 0.18% | $19.37M | 2.25% |
| IWC | iShares Micro-Cap ETF | $1.26B | 0.60% | 0.16% | $1.97M | 0.23% |
| OPTZ | Optimize Strategy Index ETF | $264.57M | 0.25% | 0.13% | $343.10K | 0.04% |
| VMO | Vanguard GlbMomntFac | $490.96M | 0.44% | 0.08% | $403.79K | 0.02% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.05% | $65.50K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.05% | $720.12K | 0.08% |
| FSML | Franklin Small Cap Enhanced ETF | $153.75M | 0.45% | 0.05% | $79.14K | <0.01% |
| VTWG | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | 0.05% | $798.58K | 0.08% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | $13.46M | 0.79% | 0.05% | $6,301.68 | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.04% | $5.01M | 0.59% |
| IWO | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | 0.04% | $6.03M | 0.71% |
| VFMO | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | 0.04% | $737.55K | 0.09% |
| PWS | Pacer WealthShield ETF | $14.55M | 0.60% | 0.04% | $5,278.68 | <0.01% |
| PKW | Invesco Buyback Achievers ETF | $1.78B | 0.63% | 0.03% | $463.62K | 0.05% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.02% | $3,502.08 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.02% | $4.26M | 0.44% |
| RESM | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | 0.02% | $1,288.98 | <0.01% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.02% | $69.20K | <0.01% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.02% | $16.58M | 1.93% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.02% | $314.12K | 0.04% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.02% | $36.76K | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | 0.02% | $225.06 | <0.01% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.02% | $944.73K | 0.11% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | 0.02% | $4.05M | 0.47% |
| ISCV | iShares Morningstar Small Cap Value ETF | $694.47M | 0.06% | 0.01% | $97.81K | 0.01% |
| BUYB | Pow Gl Buy Arch Shs USD | $205.98M | 0.57% | 0.01% | $28.91K | <0.01% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | $510.82M | 0.30% | 0.01% | $61.82K | <0.01% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | 0.01% | $9.65M | 1.00% |
| USSM | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF Accum-CAP- EUR | $30.68M | 0.30% | 0.01% | $8,263.36 | <0.01% |
| USSM | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF AccumUSD | $47.20M | 0.31% | 0.01% | $8,263.36 | <0.01% |
| VHT | Vanguard Health Care ETF | $20.70B | 0.09% | 0.01% | $2.21M | 0.23% |
| MSML | iShares MSCI USA Small-Cap ETF | $279.43M | 0.04% | <0.01% | $26.98K | <0.01% |
| SMLF | iShares MSCI USA Small-Cap Multifactor ETF | $4.28B | 0.15% | <0.01% | $394.11K | 0.05% |
| FHLC | Fidelity MSCI Health Care Index ETF | $3.95B | 0.08% | <0.01% | $327.60K | 0.04% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | $981.82M | 0.06% | <0.01% | $77.77K | <0.01% |
| XSWD | Xtrackers MSCI World Small Cap UCITS ETF -1D- USD | $17.11M | 0.25% | <0.01% | $13.59K | <0.01% |
| XSWC | Xtrackers MSCI World Small Cap UCITS ETF Accum-1C- USD | $157.24M | 0.25% | <0.01% | $13.59K | <0.01% |
| WSML | iShares MSCI World Small-Cap ETF | $668.76M | 0.30% | <0.01% | $45.51K | <0.01% |
| WDSC | SSga II Wrd Sma Accum.Shs USD | $1.69B | 0.46% | <0.01% | $111.51K | 0.01% |
| WSCD | SPDR MSCI World Small Cap UCITS ETF USD | $52.03M | 0.46% | <0.01% | $111.51K | 0.01% |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | <0.01% | $41.61K | <0.01% |
| WRDSC | UBS (Irl) ETF PLC - UBS MSCI World Small Cap UCITS ETF | $46.10M | 0.23% | <0.01% | $2,108 | <0.01% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $787.71 | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | <0.01% | $283.18K | 0.03% |
| TILT | FlexShares Morningstar US Market Factor Tilt Index Fund | $2.22B | 0.25% | <0.01% | $43.36K | <0.01% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $27.73M | 2.86% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $1.12M | 0.13% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $234.24K | 0.03% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $473.33K | 0.06% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $64.43K | <0.01% |
| FESM | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | <0.01% | $2,148.3 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in CRVS |
|---|---|---|---|---|---|---|
| LFSC | 1.41% | F/M Emerald Life Sciences Innovation ETF | $125.43M | 0.54% | $1.77M | 0.21% |
| CANC | 0.71% | Tema Oncology ETF | $216.18M | 0.75% | $1.53M | 0.18% |
| BBC | 0.65% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $224.67K | 0.03% |
| SBIO | 0.56% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $1.03M | 0.12% |
| XDNA | 0.55% | iShares Genomics Immunology and Healthcare Index ETF Trust Units | $21.79M | 0.52% | $120.57K | 0.01% |
| IDNA | 0.55% | iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | $337.92M | 0.47% | $1.83M | 0.22% |
| TMED | 0.41% | T. Rowe Price Health Care ETF | $34.83M | 0.44% | $144.26K | 0.02% |
| SURI | 0.34% | Simplify Propel Opportunities ETF | $75.80M | 2.56% | $250.75K | 0.03% |
| TDNA | 0.33% | T. Rowe Price Biotech ETF | $11.32M | 0.55% | $36.93K | <0.01% |
| XBI | 0.18% | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | $19.37M | 2.25% |
| IWC | 0.16% | iShares Micro-Cap ETF | $1.26B | 0.60% | $1.97M | 0.23% |
| OPTZ | 0.13% | Optimize Strategy Index ETF | $264.57M | 0.25% | $343.10K | 0.04% |
| VMO | 0.08% | Vanguard GlbMomntFac | $490.96M | 0.44% | $403.79K | 0.02% |
| IBBQ | 0.05% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $65.50K | <0.01% |
| OM3E | 0.05% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $720.12K | 0.08% |
| FSML | 0.05% | Franklin Small Cap Enhanced ETF | $153.75M | 0.45% | $79.14K | <0.01% |
| VTWG | 0.05% | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | $798.58K | 0.08% |
| KBFR | 0.05% | Innovator U.S. Small Cap Managed 10 Buffer ETF | $13.46M | 0.79% | $6,301.68 | <0.01% |
| IBB | 0.04% | iShares Biotechnology ETF | $11.52B | 0.44% | $5.01M | 0.59% |
| IWO | 0.04% | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | $6.03M | 0.71% |
| VFMO | 0.04% | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | $737.55K | 0.09% |
| PWS | 0.04% | Pacer WealthShield ETF | $14.55M | 0.60% | $5,278.68 | <0.01% |
| PKW | 0.03% | Invesco Buyback Achievers ETF | $1.78B | 0.63% | $463.62K | 0.05% |
| VRSD | 0.02% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $3,502.08 | <0.01% |
| VTWO | 0.02% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $4.26M | 0.44% |
| RESM | 0.02% | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | $1,288.98 | <0.01% |
| RTYS | 0.02% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $69.20K | <0.01% |
| IWM | 0.02% | iShares Russell 2000 ETF | $76.76B | 0.19% | $16.58M | 1.93% |
| RSSL | 0.02% | Global X Russell 2000 ETF | $1.47B | 0.08% | $314.12K | 0.04% |
| ITWO | 0.02% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $36.76K | <0.01% |
| RB | 0.02% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $225.06 | <0.01% |
| R2EH | 0.02% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $944.73K | 0.11% |
| SCHA | 0.02% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $4.05M | 0.47% |
| ISCV | 0.01% | iShares Morningstar Small Cap Value ETF | $694.47M | 0.06% | $97.81K | 0.01% |
| BUYB | 0.01% | Pow Gl Buy Arch Shs USD | $205.98M | 0.57% | $28.91K | <0.01% |
| TECB | 0.01% | iShares U.S. Tech Breakthrough Multisector ETF | $510.82M | 0.30% | $61.82K | <0.01% |
| VXF | 0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $9.65M | 1.00% |
| USSM | 0.01% | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF Accum-CAP- EUR | $30.68M | 0.30% | $8,263.36 | <0.01% |
| USSM | 0.01% | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF AccumUSD | $47.20M | 0.31% | $8,263.36 | <0.01% |
| VHT | 0.01% | Vanguard Health Care ETF | $20.70B | 0.09% | $2.21M | 0.23% |
| MSML | <0.01% | iShares MSCI USA Small-Cap ETF | $279.43M | 0.04% | $26.98K | <0.01% |
| SMLF | <0.01% | iShares MSCI USA Small-Cap Multifactor ETF | $4.28B | 0.15% | $394.11K | 0.05% |
| FHLC | <0.01% | Fidelity MSCI Health Care Index ETF | $3.95B | 0.08% | $327.60K | 0.04% |
| ISCG | <0.01% | iShares Morningstar Small-Cap Growth ETF | $981.82M | 0.06% | $77.77K | <0.01% |
| XSWD | <0.01% | Xtrackers MSCI World Small Cap UCITS ETF -1D- USD | $17.11M | 0.25% | $13.59K | <0.01% |
| XSWC | <0.01% | Xtrackers MSCI World Small Cap UCITS ETF Accum-1C- USD | $157.24M | 0.25% | $13.59K | <0.01% |
| WSML | <0.01% | iShares MSCI World Small-Cap ETF | $668.76M | 0.30% | $45.51K | <0.01% |
| WDSC | <0.01% | SSga II Wrd Sma Accum.Shs USD | $1.69B | 0.46% | $111.51K | 0.01% |
| WSCD | <0.01% | SPDR MSCI World Small Cap UCITS ETF USD | $52.03M | 0.46% | $111.51K | 0.01% |
| MSSM | <0.01% | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | $41.61K | <0.01% |
| WRDSC | <0.01% | UBS (Irl) ETF PLC - UBS MSCI World Small Cap UCITS ETF | $46.10M | 0.23% | $2,108 | <0.01% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $787.71 | <0.01% |
| ONEQ | <0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $283.18K | 0.03% |
| TILT | <0.01% | FlexShares Morningstar US Market Factor Tilt Index Fund | $2.22B | 0.25% | $43.36K | <0.01% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $27.73M | 2.86% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $1.12M | 0.13% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $234.24K | 0.03% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $473.33K | 0.06% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $64.43K | <0.01% |
| FESM | <0.01% | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | $2,148.3 | <0.01% |
Popular ETF Comparisons
CRVS ETF Exposure FAQ
What ETFs hold Corvus Pharmaceuticals stock?
Corvus Pharmaceuticals (CRVS) is currently held by 60 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to CRVS include SPDR (XBI), iShares (IDNA) and F/m (LFSC).
Which ETF has the largest exposure to CRVS?
The ETF with the largest exposure to CRVS is SPDR (XBI), with approximately $19.37M in market value exposure.
How much CRVS stock is held by ETFs?
ETFs currently hold approximately $26.31M worth of Corvus Pharmaceuticals (CRVS) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.